NL-OMON52282招募中2 期
A multicenter phase II randomized trial to evaluate systemic therapy versus systemic therapy in combination with stereotactic radiotherapy in patients with metastatic colorectal cancer - SIRIUS
niversitair Medisch Centrum Utrecht0 个研究点目标入组 105 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Histological proof of colorectal carcinoma (CRC)
- •- Colorectal metastatic disease
- •- Ten or less metastases as determined by the UCMU central review
- •- Stable disease or partial response after induction chemotherapy according to
- •RECIST 1.1 criteria
- •- Written informed consent
- •For all in- and exclusion criteria we want to refer to chapter 4 of the
排除标准
- •- Possible treatment with curative intent according to local tumor board
- •- Substantial overlap with a previously treated radiation volume. Previous
- •radiotherapy is allowed as long as the composite plan meets dose constraints
- •- Contra-indication MR-LINAC (pacemaker or implantable
- •cardioverter-defibrillator)
- •For all in- and exclusion criteria we want to refer to chapter 4 of the
研究者
相似试验
招募中
2 期
A multicenter randomized phase II trial evaluating the efficacy and safety of intrapericardial left superior pulmonary vein ligation or division for prevention of thrombosis in the stumpmalignant tumor of the lungJPRN-UMIN000036037iigata Chest Surgery Study Group60
进行中（未招募）
不适用
A multicenter randomized phase II Trial assessing the activity of Gemcitabine - Oxaliplatin chemotherapy alone or in combination with Cetuximab in patients with advanced biliary cancer - BINGOadenocarcinoma of the biliary tract ( gallbladder, intra and/ or extrahepatic bile ducts, ampulla of Vater)EUCTR2007-001200-20-DEMedizinische Hochschule Hannover100
进行中（未招募）
1 期
A randomized, multi-center phase II trial to assess the efficay of 5-azacytidine added to standard primery therapy in elderly patients with newly diagnosed AML. - AML-AZAThe disease under investigation is newly diagnosed Acute Myeloid Leucemia (AML) in elderly patients.MedDRA version: 13.1Level: PTClassification code 10000880Term: Acute myeloid leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-004583-40-DEniversitaetsklinikum Muenster234
尚未招募
2 期
A randomized phase II multicenter study to assess the tolerability and efficacy of the addition of ibrutinib to 10-day decitabine in UNFIT (i.e. HCT-CI >= 3) AML and high risk myelodysplasia (MDS) (IPSS-R > 4.5) patients aged >= 66 years. A study in the frame of the masterprotocol of parallel randomized phase II studies in UNFIT-older AML/high-risk MDS patientsmyelodysplastic syndromes10024324Acute myeloid leukemiaNL-OMON53140HOVO70
进行中（未招募）
1 期
A randomized study to assess the tolerability and efficacy of the addition of midostaurin to 10-day decitabine treatment in patients with AML and high risk myelodysplasia (MDS), UNFIT for intensive chemotherapy. ,EUCTR2018-000047-31-NLHOVON Foundation140